Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations

NeuroImage

Volumn 118, Issue , 2015, Pages 126-132

  Nakamura, Kunio ^a,b   Brown, Robert A ^a   Narayanan, Sridar ^a,c   Collins, D Louis ^a   Arnold, Douglas L ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NEURORX RESEARCH   (Canada)

Author keywords

Brain atrophy; Brain parenchymal fraction; Diurnal change; MRI

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); HUMAN; IMAGE ANALYSIS; MILD COGNITIVE IMPAIRMENT; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL; ADOLESCENT; ADULT; AGED; BRAIN; FEMALE; IMAGE PROCESSING; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CIRCADIAN RHYTHM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 84937567816     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.05.077     Document Type: Article

References (41)

1. Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatr. Phys. Gerichtl. Med. 1907, 64:146-148.
2. Ashburner J., Ridgway G.R. Symmetric diffeomorphic modeling of longitudinal structural MRI. Front. Neurosci. 2012, 6:197.
3. Bates D., Maechler M. Ime4: Linear Mixed-Effects Models Using S4 Classes R Package Version 0.999375-32 2009.
4. Caramanos Z., Fonov V.S., Francis S.J., Narayanan S., Pike G.B., Collins D.L., Arnold D.L. Gradient distortions in MRI: characterizing and correcting for their effects on SIENA-generated measures of brain volume change. NeuroImage 2010, 49:1601-1611.
5. Chard D.T., Parker G.J., Griffin C., Thompson A.J., Miller D.H. The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. J. Magn. Reson. Imaging 2002, 15:259-267.
6. Collins D.L., Neelin P., Peters T.M., Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 1994, 18:192-205.
7. Coupe P., Yger P., Prima S., Hellier P., Kervrann C., Barillot C. An optimized blockwise nonlocal means denoising filter for 3-D magnetic resonance images. IEEE Trans. Med. Imaging 2008, 27:425-441.
8. Dawson J. The histology of multiple sclerosis. Trans. R. Soc. Edinb. 1916, 50:517-740.
9. Duning T., Kloska S., Steinstrater O., Kugel H., Heindel W., Knecht S. Dehydration confounds the assessment of brain atrophy. Neurology 2005, 64:548-550.
10. Eskildsen S.F., Coupe P., Fonov V., Manjon J.V., Leung K.K., Guizard N., Wassef S.N., Ostergaard L.R., Collins D.L. BEaST: brain extraction based on nonlocal segmentation technique. NeuroImage 2012, 59:2362-2373.
11. Fisher E. Measurement of CNS atrophy. Multiple Sclerosis Therapeutics 2011, 128-149. Cambridge University Press. J.A. Cohen, R.A. Rudick (Eds.).
12. Fisher E., Cothren J.R.M., Tkach J.A., Masaryk T.J., Cornhill J.F. Knowledge-based 3D segmentation of the brain in MR images for quantitative multiple sclerosis lesion tracking. Proc. SPIE 1997, 3034:19-25. (Medical Imaging).
13. Fisher E., Lee J.C., Nakamura K., Rudick R.A. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann. Neurol. 2008, 64:255-265.
14. Fitzmaurice G.M., Laird N.M., Ware J.H. Applied Longitudinal Analysis 2004, Wiley-Interscience, Hoboken, N.J.
15. Fonov V., Evans A., McKinstry R., Almli C., Collins D. Unbiased nonlinear average age-appropriate brain templates from birth to adulthood. NeuroImage 2009, 47:S102.
16. Fotenos A.F., Snyder A.Z., Girton L.E., Morris J.C., Buckner R.L. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. Neurology 2005, 64:1032-1039.
17. Fox N.C., Freeborough P.A. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J. Magn. Reson. Imaging 1997, 7:1069-1075.
18. Fox N.C., Cousens S., Scahill R., Harvey R.J., Rossor M.N. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch. Neurol. 2000, 57:339-344.
19. Fox R.J., Campbell Cree B.A., De Seze J., Gold R., Hartung H.P., Jeffery D., Kappos L., Kaufman M., Montalban X., Weinstock-Guttman B., Anderson B., Natarajan A., Ticho B., Duda P. MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study. Neurology 2014, 82:1491-1498.
20. Gold R., Kappos L., Arnold D.L., Bar-Or A., Giovannoni G., Selmaj K., Tornatore C., Sweetser M.T., Yang M., Sheikh S.I., Dawson K.T., Investigators D.S. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N. Engl. J. Med. 2012, 367:1098-1107.
21. Gullans S.R., Verbalis J.G. Control of brain volume during hyperosmolar and hypoosmolar conditions. Annu. Rev. Med. 1993, 44:289-301.
22. Holland D., Brewer J.B., Hagler D.J., Fennema-Notestine C., Dale A.M., Weiner M., Thal L., Petersen R., Jack C.R., Jagust W. Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc. Natl. Acad. Sci. 2009, 106:20954-20959.
23. Leung K.K., Ridgway G.R., Ourselin S., Fox N.C. Consistent multi-time-point brain atrophy estimation from the boundary shift integral. NeuroImage 2012, 59:3995-4005.
24. McEvoy L.K., Edland S.D., Holland D., Hagler D.J., Roddey J.C., Fennema-Notestine C., Salmon D.P., Koyama A.K., Aisen P.S., Brewer J.B. Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 2010, 24:269.
25. Miller D.H., Soon D., Fernando K.T., MacManus D.G., Barker G.J., Yousry T.A., Fisher E., O'Connor P.W., Phillips J.T., Polman C.H., Kappos L., Hutchinson M., Havrdova E., Lublin F.D., Giovannoni G., Wajgt A., Rudick R., Lynn F., Panzara M.A., Sandrock A.W., Investigators Affirm MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology 2007, 68:1390-1401.
26. Nakamura K., Rudick R.A., Lee J.C., Foulds P., Fisher E. Effect of Intramuscular Interferon beta-1a on Gray Matter Atrophy in Relapsing-Remitting Multiple Sclerosis 2010, American Academy of Neurology (AAN), Toronto, Ontario, Canada.
27. Nakamura K., Brown R.A., Araujo D., Narayanan S., Arnold D.L. Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: implications for monitoring atrophy in clinical studies. NeuroImage Clin. 2014, 6:166-170.
28. Nakamura K., Guizard N., Fonov V.S., Narayanan S., Collins D.L., Arnold D.L. Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis. NeuroImage Clin. 2014, 4:10-17.
29. Ridler T., Calvard S. Picture thresholding using an iterative selection method. IEEE Trans. Syst. Man Cybern. 1978, 8:630-632.
30. R-Team R: A Language and Environment for Statistical Computing 2012, R Foundation for Statistical Computing, Vienna, Austria, (2007).
31. Rudick R., Fisher E., Lee J.-C., Simon J., Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 1999, 53:1698.
32. Rudick R.A., Fisher E., Lee J.C., Duda J.T., Simon J. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a. Mult. Scler. 2000, 6:365-372.
33. Santago P., Gage H.D. Statistical-models of partial volume effect. IEEE Trans. Image Process. 1995, 4:1531-1540.
34. Scahill R.I., Frost C., Jenkins R., Whitwell J.L., Rossor M.N., Fox N.C. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch. Neurol. 2003, 60:989-994.
35. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. Med. Imaging IEEE Trans. 1998, 17:87-97.
36. Smith S.M., De Stefano N., Jenkinson M., Matthews P.M. Normalized accurate measurement of longitudinal brain change. J. Comput. Assist. Tomogr. 2001, 25:466-475.
37. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., De Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 2002, 17:479-489.
38. Sormani M.P., Arnold D.L., De Stefano N. Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Ann. Neurol. 2014, 75:43-49.
39. Stelzmann R.A., Norman Schnitzlein H., Reed Murtagh F. An English translation of Alzheimer's 1907 paper, "Über eine eigenartige Erkankung der Hirnrinde". Clin. Anat. 1995, 8:429-431.
40. Whittall K.P., MacKay A.L., Graeb D.A., Nugent R.A., Li D.K., Paty D.W. In vivo measurement of T2 distributions and water contents in normal human brain. Magn. Reson. Med. 1997, 37:34-43.
41. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 2001, 20:45-57.